Related Experiment Videos
Infantile encephalopathy associated with the MELAS A3243G mutation
1Departments of Neurology and Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
The Journal of Pediatrics
|June 4, 1999
Summary
The A3243G mitochondrial DNA mutation, typically linked to MELAS syndrome, can cause severe early-onset psychomotor delay in infants. This mutation
Area of Science:
- Genetics and Molecular Biology
- Neurology
- Pediatrics
Background:
- MELAS syndrome (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) is a mitochondrial disorder.
- It is commonly associated with the A3243G point mutation in the mitochondrial DNA tRNALeu(UUR) gene.
- Typical presentation involves childhood-onset neurological deficits, seizures, and ragged red fibers.
Purpose of the Study:
- To report three unrelated children with the A3243G mutation presenting with atypical, early-onset severe psychomotor delay.
- To highlight the expanded phenotypic spectrum of the A3243G mutation beyond classic MELAS syndrome.
- To investigate the correlation between mutant mitochondrial DNA levels and neurological phenotype.
Main Methods:
- Clinical case series of three unrelated infants diagnosed with the A3243G mutation.
- Detailed clinical evaluation including neurological examinations, brain MRI, and muscle biopsy.
- Quantification of mutant mitochondrial DNA (mtDNA) proportion in muscle and blood samples.
Main Results:
- All three patients presented with severe psychomotor delay in early infancy, deviating from typical childhood onset.
- Clinical presentations included features resembling Leigh syndrome, refractory seizures, and atypical retinal changes.
- Low proportions of mutant mtDNA were found in peripheral tissues, with poor correlation to the neurological phenotype.
Conclusions:
- The A3243G mutation exhibits a broader phenotypic spectrum than previously recognized, including severe infantile psychomotor delay.
- Atypical presentations and early onset can occur despite low levels of mutant mtDNA in peripheral tissues.
- Factors beyond mutant mtDNA abundance in peripheral tissues likely influence the phenotypic expression of this mutation.